Pfizer Inc. et al v. Sandoz Inc.
| Delaware District Court | |
| Case #: | 1:24-cv-01244 |
| Nature of Suit | 835 Property Rights - Patent – Abbreviated New Drug Application |
| Cause | 35:271 Patent Infringement |
| Case Filed: | Nov 12, 2024 |
| Last checked: Thursday Nov 14, 2024 2:09 AM EST |
|
Defendant
Sandoz Inc.
|
|
|
Plaintiff
PF PRISM IMB B.V.
|
Represented By
|
|
Plaintiff
Pfizer Inc.
|
Represented By
|
| Docket last updated: 11/15/2024 11:59 PM EST |
| Friday, November 15, 2024 | ||
| 8 | 8
motion
Stipulation to EXTEND Time
Fri 11/15 9:31 AM
STIPULATION TO EXTEND TIME for Sandoz to move, answer, or otherwise respond to the Complaint to January 13, 2025 - filed by Sandoz Inc.. (Gattuso, Dominick) |
|
| Wednesday, November 13, 2024 | ||
| 7 | 7
service
Summons Returned Executed
Wed 11/13 2:06 PM
SUMMONS Returned Executed by Pfizer Inc., PF PRISM IMB B.V..Sandoz Inc. served on 11/13/2024, answer due 12/4/2024. (Dellinger, Megan) |
|
| Tuesday, November 12, 2024 | ||
| 6 | 6
service
Summons Issued
Wed 11/13 8:14 AM
Summons Issued as to Sandoz Inc. on 11/12/2024. (scs) |
|
| 5 | 5
misc
Disclosure Statement - Rule 7.1
Wed 11/13 8:12 AM
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Pfizer Inc., PF PRISM IMB B.V.. (scs) |
|
| 4 | 4
misc
Patent/Trademark Report to Commissioner of Patents
Wed 11/13 8:11 AM
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,791,140 B2. (scs) |
|
| 3 | 3
misc
ANDA Form
Wed 11/13 8:10 AM
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/02/2024. Date of Expiration of Patent: 12/14/2030. Thirty Month Stay Deadline: 4/2/2027. (scs) |
|
| 2 | 2
misc
Magistrate Consent Forms
Wed 11/13 8:08 AM
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) |
|
| 1 | 1
11
pgs
cmp
Complaint
Wed 11/13 8:06 AM
COMPLAINT for ANDA/Patent Infringement against Sandoz Inc. (Filing fee $ 405, receipt number ADEDC-4545832) - filed by Pfizer Inc., PF PRISM IMB B.V..(scs) |
|
|
Att: 1
Exhibit A,
|
||
|
Att: 2
Civil Cover Sheet
|
||